Atrial Fibrillation Clinical Trial 20193152

[LCID Study Number: 20193152]

Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation (OPTION)

The purpose of this study is to determine if left atrial appendage closure with the WATCHMAN FLX Device is a reasonable alternative to oral anticoagulation following percutaneous catheter ablation for high risk patients with non-valvular atrial fibrillation (AF).

Disease/Condition: Atrial Fibrillation

Department: Cardiology – Anticoagulation

Status: Active, Not Recruiting

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-1901

Protocol #: 20193152
Principal Investigator(s): Ghulam M. Chaudhry
Study Coordinator(s): Jean Byrne
Trial Phase: Sponsor Initiated Study Category B Device